DeepCardio is driving forward
in pursuit of new innovation and discovery.
2026
- 03 SmartECG-EF Approved by MFDS (Approval No. 26-3)
- 02 Selected as Superstar Startup by the Ministry of SMEs and Startups
- 02 Selected for Scale-up TIPS by the Korea SMEs and Startups Agency
2025
- 12 Series B1 Completed
- 09 MOU with Sanofi
2024
- 09 Certified as the 8th Innovative Medical Device Software Manufacturer
- 08 Partnership Established with GE HealthCare Korea
- 07 Designated as "Innovative Product" by Public Procurement Service (SmartECG-AF, No. 2024-163)
- 05 Selected as First Penguin Company by Korea Credit Guarantee Fund (No. 2024-0036)
- 01 SmartECG-AF Approved by MFDS (No. 24-22 — World's First of Its Kind)
2023
- 10 Designated as Innovative Medical Device (Integrated No. 49)
- 10 Selected for Innovative Medical Technology Assessment (No. 2023-091)
- 10 AI Startup Korea 100 Selection
- 06 Relocated to Songdo IT Center
- 03 Medical Device GMP Certification Obtained
- 03 ISO 13485 Certification Completed
2022
- 09 Launched Pilot Service for Cardiac Age Assessment at Inha University Hospital Health Promotion Center
- 04 Series A Investment Secured (SoftBank Ventures, Daily Partners)
- 04 MOU Signed with GE HealthCare Korea
2021
- 12 MOU Signed with Seoul National University Cardiology
- 12 MOU Signed with Chungbuk National University Cardiology
- 12 MOU Signed with Korea University Guro Hospital Cardiology
- 12 MOU Signed with Gachon University Gil Medical Center Cardiology
- 12 MOU Signed with Chung-Ang University Cardiology
- 09 Technology Agreement Signed with Inha University Hospital
- 09 MOU Signed with Yonsei University Severance Hospital Cardiology
- 06 Certified as Venture Company (Innovation Growth Type)
- 03 Selected as Tech Valley Company by Korea Technology Finance Corporation
2020
- 11 DeepCardio Co., Ltd. Founded